Cellect Awarded NIS 3.5 Million BIRD Foundation Grant for the Development and Commercialization of Innovative Stem Cell Selection Technology
June 15, 2016 16:30 ET
|
Cellect Biomed
KFAR SABA, Israel, June 15, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology which enables the functional selection of...
Cellect to be Included in TASE Indices
June 14, 2016 09:02 ET
|
Cellect Biomed
KFAR SABA, Israel, June 14, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or “the Company”), a developer of innovative technology which enables the functional selection of...
Cellect Granted Canadian Patent For Its Cell Selection Technology Platform
May 09, 2016 09:21 ET
|
Cellect Biomed
TEL AVIV, Israel, May 09, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology that enables the functional selection of stem...
Cellect Announces the Signing of a Collaboration Agreement with Accellta
April 19, 2016 12:00 ET
|
Cellect Biomed
- On the Path to a First License Agreement - TEL AVIV, Israel, April 19, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative...
Cellect Announces Receipt of IRB Approval to Conduct Its Clinical Trial in Leukemia Patients
March 07, 2016 09:00 ET
|
Cellect Biomed
TEL AVIV, Israel, March 07, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, announces today it...
Cellect Announces a NIS 8 Million Private Placement Led by Foreign Investors
February 16, 2016 09:30 ET
|
Cellect Biomed
TEL-AVIV, Israel, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a developer of innovative technology which enables the functional selection of stem cells, announced today the...
Cellect Receives Approval to Commence Human Trial in Healthy Volunteers at the Schneider Medical Center
December 16, 2015 11:30 ET
|
Cellect Biomed
TEL-AVIV, Israel, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) (“Cellect” or the “Company”), a developer of innovative technology which enables the functional selection of...
Cellect Announces Positive Results From BMT Safety Test
December 09, 2015 10:36 ET
|
Cellect Biomed
TEL AVIV, Israel, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem...
Cellect Biomed to Present at ASH 57th Annual Meeting on December 6
December 02, 2015 11:45 ET
|
Cellect Biomed
TEL AVIV, Israel, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD), a company specializing in the development of an innovative technology platform which enables the functional...
Cellect Biomed Announces Key Leadership Changes
November 09, 2015 08:30 ET
|
Cellect Biomed
TEL-AVIV, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Cellect Biomed Ltd. (TASE:CLBD) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem...